Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 11, 2006, Pages 3963-3965

  Onyewu, Chiatogu ^a   Afshari, Natalie A ^a,b   Heitman, Joseph ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CYCLOSPORIN; FLUCONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG POTENTIATION; DRUG TARGETING; FUNGAL VIRULENCE; IN VIVO STUDY; KERATOMYCOSIS; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIFUNGAL AGENTS; CALCINEURIN; CANDIDA ALBICANS; CANDIDIASIS; CORNEAL DISEASES; CYCLOSPORINE; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENTS; KERATITIS; MICE; MICE, INBRED BALB C;

EID: 33750582208     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00393-06     Document Type: Article

References (19)

1. Bader, T., B. Bodendorfer, K. Schroppel, and J. Morschhauser. 2003. Calcineurin is essential for virulence in Candida albicans. Infect. Immun. 71:5344-5354.
2. Bader, T., K. Schroppel, S. Bentink, N. Agabian, G. Kohler, and J. Morschhauser. 2006. Role of calcineurin in stress resistance, morphogenesis, and virulence of a Candida albicans wild-type strain. Infect. Immun. 74:4366-4369.
3. Blankenship, J. R., F. L. Wormley, M. K. Boyce, W. A. Schell, S. G. Filler, J. R. Perfect, and J. Heitman. 2003. Calcineurin is essential for Candida albicans survival in serum and virulence. Eukaryot. Cell. 2:422-430.
4. Cruz, M. C., A. L. Goldstein, J. R. Blankenship, M. Del Poeta, D. Davis, M. E. Cardenas, J. R. Perfect, J. H. McCusker, and J. Heitman. 2002. Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J. 21:546-559.
5. Gillum, A. M., E. Y. Tsay, and D. R. Kirsch. 1984. Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198:179-182.
6. Klotz, S. A., C. C. Penn, G. J. Negvesky, and S. I. Butrus. 2000. Fungal and parasitic infections of the eye. Clin. Microbiol. Rev. 13:662-685.
7. Manzouri, B., G. C. Vafidis, and R. K. Wyse. 2001. Pharmacotherapy of fungal eye infections. Exp. Opin. Pharmacother. 2:1849-1857.
8. Moosa, M. Y., J. D. Sobel, H. Elhalis, W. Du, and R. A. Akins. 2004. Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium. Antimicrob. Agents Chemother. 48:161-167.
9. O'Day, D. M. 1996. Fungal keratitis. In J. S. Pepose, G. N. Holland, and K. R. Wilhemus (ed.), Ocular infections and immunity. Mosby, St. Louis, Mo.
10. Onyewu, C., F. L. Wormley, Jr., J. R. Perfect, and J. Heitman. 2004. The calcineurin target, Crz1, functions in azole tolerance but is not required for virulence of Candida albicans. Infect. Immun. 72:7330-7333.
11. Rex, J. H., T. J. Walsh, J. D. Sobel, S. G. Filler, P. G. Pappas, W. E. Dismukes, J. E. Edwards, et al. 2000. Practice guidelines for the treatment of candidiasis. Clin. Infect. Dis. 30:662-678.
12. Sanglard, D., F. Ischer, O. Marchetti, J. Entenza, and J. Bille. 2003. Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol. Microbiol. 48:959-976.
13. Tanure, M. A., E. J. Cohen, S. Sudesh, C. J. Rapuano, and P. R. Laibson. 2000. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea 19:307-312.
14. Thomas, P. A. 2003. Current perspectives on ophthalmic mycoses. Clin. Microbiol. Rev. 16:730-797.
15. Thomas, P. A. 2003. Fungal infections of the cornea. Eye 17:852-856.
16. White, T. C. 1998. Antifungal drug resistance in Candida albicans. ASM News 63:427-433.
17. White, T. C., S. Holleman, F. Dy, L. F. Mirels, and D. A. Stevens. 2002. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 46:1704-1713.
18. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.
19. Wu, T. G., K. R. Wilhelmus, and B. M. Mitchell. 2003. Experimental keratomycosis in a mouse model. Investig. Ophthalmol. Vis. Sci. 44:210-216.